1. Introduction {#sec1}
===============

*Helicobacter pylori* (*H. pylori*) is one of the most common bacterial infections in humans \[[@B1]\]. The presence of the organism *H. pylori* (initially termed*Campylobacter pyloridis*) in the antral mucosa of humans was first reported in 1983 \[[@B2]\].*H. pylori* has been closely linked to chronic gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma \[[@B3], [@B4]\]. The International Agency for Research on Cancer of the World Health Organization (WHO) has designated *H. pylori* as a Group 1 carcinogen \[[@B5]\]. Besides gastrointestinal diseases, recent data seems to suggest a possible association of this microorganism with other conditions such as anemia \[[@B6]\], altered serum levels of lipoproteins \[[@B7]\], and coronary atherosclerosis \[[@B8]\]. Although *H. pylori*is present in the stomach of about half of the world\'s population, we do not yet clearly understand its transmission. Available data suggests that oral-oral and fecal-oral routes are the most likely routes of transmission of this organism \[[@B9], [@B10]\]. However, no extragastric reservoirs of *H. pylori*have been clearly demonstrated. A recent study has reported the detection of the organisms in soil samples in public playgrounds suggesting the role of the abovementioned routes in the transmission of the organism \[[@B11]\]. However, the likelihood of transmission of infection through contaminated soil needs to be clarified. Although organisms resembling *H. pylori*may be detected in other animals, none, except non-human primates \[[@B12]\] and cats \[[@B13]\], harbor *H. pylori*. Infections by *Helicobacter* species (*H. heilmannii*and*H. felis*) have been reported in dogs and cats \[[@B14], [@B15]\]. It has been suggested that the microorganism may be transmitted orally and has been detected in dental plaque and saliva \[[@B16]--[@B18]\]. But whether the oral cavity serves as an extragastric reservoir for *H. pylori*or harbors the organism only transiently, is not yet clear (the organism being only a transient inhabitant of this ecological niche or not). If the oral cavity is an extragastric reservoir of the *H. pylori*, it may be clinically significant from the treatment aspect as the microorganisms residing in the dental plaque are afforded protection from systemically administered antimicrobial agents. Treatment of *H. pylori*infection usually involves a combination of antibiotics, acid suppressors, and stomach protectors. Despite the current treatment regimens that lead to successful management of *H. pylori*---positive chronic gastritis, the reinfection rate is relatively high \[[@B19]\]. One of the suggested mechanisms of reinfection is the possible recolonization from the dental plaque \[[@B20]\]. A large number of studies have been carried out among various populations to determine whether dental plaque and periodontal disease are associated with *H. pylori* infection. This paper attempts to review the current evidence regarding the role of oral cavity as an extragastric reservoir of *H. pylori*.

2. Materials and Methods {#sec2}
========================

2.1. Literature Search {#sec2.1}
----------------------

A systematic review was conducted in January 2013. All relevant studies published between January 1990 and December 2012 were identified and included in the systematic analysis. Two authors independently searched the Medline, EMBASE, Cochrane Library, Web of Science, Google Scholar, and Scopus databases for relevant studies. The search was carried out by using a combined text and the MeSH search strategies: using the key words *Helicobacter*, *Helicobacter pylori*, and *H. pylori* in combination with dental plaque, periodontitis, and oral hygiene. We also examined the bibliographies from identified studies, reviews, and gray literature. The last search was conducted on December 31, 2012.

2.2. Study Selection Criteria {#sec2.2}
-----------------------------

Studies reporting the identification of *Helicobacter pylori* in dental plaque, coinfection of periodontitis and *H. pylori,* effect of periodontal therapy on *H. pylori,*and effect of treatment of*H. pylori*infection on periodontal problems were included in the review. The types of studies included were cross-sectional, experimental studies and interventional studies. Patients in all age groups were included. Studies presented solely in the form of abstracts in scientific conferences and studies published in languages other than English were not considered in this review.

2.3. Data Extraction Considerations {#sec2.3}
-----------------------------------

Data extracted from each of the included studies was referred to the study design, the method used to study the presence of *H. pylori,*and the type of association between the periodontal problems and *H. pylori* infection. The data was presented in a tabular form with the variables in quantitative and qualitative format.

The papers were grouped according to the content of the study and presented in 8 tables based on the date of publication of the study. Tables [1](#tab1){ref-type="table"}--[4](#tab4){ref-type="table"} depict the presence of *H. pylori*in dental plaque. Tables [5](#tab5){ref-type="table"} and [6](#tab6){ref-type="table"} enumerate the coinfection and association studies between *H. pylori* infection and periodontal disease. [Table 7](#tab7){ref-type="table"} shows the effect of anti-*H. pylori* therapy on its presence in dental plaque. Studies on the effects of periodontal treatment on *H. pylori* presence in dental plaque and gastric infection are listed are [Table 8](#tab8){ref-type="table"}.

2.4. Methods of Detection of *H. pylori* {#sec2.4}
----------------------------------------

Various methods have been employed to detect the presence of the bacterium *H. pylori* in the gastrointestinal mucosa. These include histology, culture, urease test, serologic tests, urea breath test, and polymerase chain reaction targeting specific nuclear material of the microorganism \[[@B3]\]. Histological methods using conventional hematoxylin and eosin staining can be used to visualize *H. pylori* while use of special stains such Warthin-Starry and Giemsa staining can enhance the histologic identification of the microorganism. By employing culture methods, antimicrobial susceptibility tests can be performed. Urease tests and urea breath tests are based on the fact that the microorganisms are associated with large amounts of urease activity while serologic tests detect the levels of antibodies such as IgG and IgA in the serum that is elevated in response to an infection by *H. pylori*. Several different polymerase chain reaction (PCR) methods which differ in their target DNA have been developed for the diagnosis of *H. pylori* infection and these can help to differentiate between *H. pylori* strains.

2.5. *H. pylori* in Dental Plaque {#sec2.5}
---------------------------------

The prevalence of *H. pylori* in the dental plaque has been studied by several investigators. The results of these studies showed wide variation and this seems to depend at least in part on the method employed to detect the bacterium in the dental plaque. As mentioned earlier, investigators have used several methods to detect the presence of the bacterium in the dental plaque and these include urease tests (rapid urease/CLO test), PCR, histology, culture, and immunoassays.

2.6. Prevalence Data as Reported in Studies Utilizing Urease Tests {#sec2.6}
------------------------------------------------------------------

The prevalence of *H. Pylori* in the dental plaque of study participants reported by investigators using urease tests is given in [Table 1](#tab1){ref-type="table"}. The prevalence of *H. pylori* in dental plaque in these studies generally ranged from 50% to 100% except in 3 studies. In 2 of these studies the prevalence rates reported were 44.8% \[[@B21]\] and 43% \[[@B22]\] while the lowest rate reported was 18.2% \[[@B23]\].

2.7. Prevalence Data as Reported in Studies Utilizing PCR {#sec2.7}
---------------------------------------------------------

The prevalence of *H. pylori* in the dental plaque of study participants reported by investigators using PCR is given in [Table 2](#tab2){ref-type="table"}. The prevalence rates reported in these studies ranged from 0-100% and were generally lower than those reported in studies in which urease tests were used to detect the presence of *H. pylori* in dental plaque. However, out of the 34 studies reviewed in this category, only 7 studies reported a prevalence rate exceeding 50%. Of these 7 studies, 6 were conducted amongst Asian populations.

2.8. Prevalence Data as Reported in Studies Utilizing Culture {#sec2.8}
-------------------------------------------------------------

The prevalence of *H. pylori* in the dental plaque reported by investigators using culture method is given in [Table 3](#tab3){ref-type="table"}. The prevalence rates reported in these studies were generally below 50% with about half studies reported less than 10% prevalence. In 2 of these studies \[[@B24], [@B25]\], the microorganism could not be cultured from the dental plaque.

2.9. Prevalence Data as Reported in Studies Utilizing Immunoassays {#sec2.9}
------------------------------------------------------------------

The prevalence of *H. pylori* in the dental plaque reported by investigators using immunoassays is given in [Table 4](#tab4){ref-type="table"}. Using this method for detection of *H. pylori* in dental plaque, 2 studies \[[@B26], [@B27]\] reported a high prevalence (\>65%) of the microorganism in dental plaque while other 2 studies \[[@B28], [@B29]\] reported a very low prevalence (0 and 11%).

2.10. Prevalence of Coinfection of Gastric Mucosa and Dental Plaque by *H. pylori* {#sec2.10}
----------------------------------------------------------------------------------

The summary of studies which have evaluated the prevalence of coinfection of gastric mucosa and dental plaque by *H. pylori* among the study participants is given in [Table 5](#tab5){ref-type="table"}. The prevalence rate of coinfection among the respective study populations reported by different investigators ranged from as low as 1% to as high as 82.1%. This wide variation in the prevalence rates of coinfection may be partly due to the difference in the diagnostic tests employed by various investigators to detect the bacterium in the dental plaque. Studies utilizing urease tests to detect the presence of the microorganism in the dental plaque have reported very high prevalence rates. Except for one study which reported a 25.2% prevalence of coinfection, all the other studies utilizing urease tests have reported a coinfection rate in excess of 32%, with one study reporting a prevalence rate of 81.3% \[[@B30]\]. In studies involving PCR, the prevalence rates have ranged between 0% and 47.6% with only 5 out of the 11 studies reporting a prevalence rate above 30%. Low rates of prevalence of coinfection were reported when microbial culture was employed to detect *H. pylori* from the dental plaque. Out of the 5 studies reviewed which employed microbial culture, the rates of prevalence reported were 1%, 1.4%, 6.9%, 14.6%, and 18%, respectively \[[@B16], [@B31]--[@B33]\]. In the 2 studies reviewed which used immunoassays for detection of pathogen in dental plaque samples, the prevalence rates reported were 23.6% and 47.6% \[[@B27]\]. Among patients with gastrointestinal colonization by *H. pylori*, the prevalence of coinfection in dental plaque was reported to be in the range of 25.2% to 100%. In studies involving the use of urease test only 2 out of the 8 studies reported a prevalence rate of less than 50%; 0% to 100% in PCR studies with 5 out of the 11 studies reviewed reported a prevalence rate above 50%; 1.7% to 30% in the 5 studies using microbial culture; and 23.6% to 82.1% in studies using immunoassays.

2.11. *H. pylori* and Periodontal Disease {#sec2.11}
-----------------------------------------

Few studies have evaluated the relationship between gingival and periodontal disease and *H. pylori* infection. While some investigators \[[@B34], [@B35]\] have reported a positive association between the two conditions, others have reported that there was no association between *H. pylori* infection and periodontal diseases \[[@B18], [@B36]\]. [Table 6](#tab6){ref-type="table"} shows the studies which have evaluated the relationship between periodontal disease and *H. pylori* infection.

A large-scale epidemiological study which evaluated the relationship between *H. pylori* infection and abnormal periodontal conditions by Dye et al. \[[@B34]\] utilized the data from the first phase of the third National Health and Nutrition Examination Survey. A total of 4504 participants aged 20 to 59 years who completed a periodontal examination and tested positive for *H. pylori* antibodies were examined. Periodontal pockets with a depth of 5 mm or more were associated with increased odds of *H. pylori*seropositivity after adjustment for sociodemographic factors. The authors reported that this association is comparable to the independent effects of poverty on *H. pylori* and concluded that poor periodontal health, characterized by advanced periodontal pockets, may be associated with *H. pylori* infection in adults, independent of poverty status.

Nested polymerase chain reaction (PCR) was employed by Umeda et al. \[[@B37]\] to clarify whether the oral cavity acts as a reservoir for *H. pylori*. The existence of *H. pylori* in the oral cavity was determined by nested PCR in 57 subjects and by culture method in 18 subjects. The presence of periodontopathic bacteria was also determined by 16S rRNA-based PCR method. Although *H. pylori* was rarely detected in the oral cavity by culture technique, it was frequently detected (35.1%) by nested PCR, especially among periodontitis patients who had the bacterium in the gastrointestinal tract (46.4%). Among the subjects who harbored *H. pylori* in the stomach or duodenum, 41.2% of patients with periodontal pockets ≥4 mm and 9.1% of subjects without periodontal pockets showed *H. pylori* in dental plaque. They also reported that one patient who had periodontal pockets retained *H. pylori* in the oral cavity even after eradication of the bacterium from the stomach and duodenum. Most (8/10) of the patients who had *H. pylori* in dental plaque harbored *Bacteroides forsythus* in their oral cavities. Based on the previously mentioned findings, the authors concluded that close attention should be given to periodontitis patients who harbor *H. pylori* in the oral cavity.

Association between periodontal disease and *H. pylori* infection was tested in a case-control study among 134 dyspeptic patients reporting for upper gastrointestinal endoscopy \[[@B38]\]. The periodontal status of the patients was examined as a dichotomous variable with patients being described as being either diseased or healthy depending on their periodontal status. Among the cases, 30 subjects out of 65 (46.2%) had periodontal disease compared to only 20 out of 69 (29%) in comparison to the controls. Although the univariate analysis suggested that the relationship was significant, when analyzed by logistic regression, the difference was found to be not significant.

Lack of association between *H. pylori* infection and periodontal disease was reported by Berroteran et al. \[[@B39]\] based on the results from their study of a Venezuelan population. Gingival and Plaque indices were used to assess the gingival and oral hygiene status of the 32 dyspeptic patients and 20 asymptomatic subjects. It was found that patients with poor oral hygiene and periodontal status had a similar prevalence of *H. pylori* to patients with good-to-moderate dental hygiene.

To elucidate the possible sources of *H. pylori* infection in an isolated, rural population in Guatemala, Dowsett et al. \[[@B18]\] examined 242 subjects in family units. Periodontal status, *H. pylori* antibody status, and presence of *H. pylori* in the dental plaque, dorsum of tongue, and fingernails were recorded. PCR based on 16S rRNA gene of *H. pylori* were employed for the detection of the microorganism in the plaque, tongue, and finger nail samples. It was found that there was no statistically significant relationship between *H. pylori* status and periodontal disease. A high rate of oral carriage was found irrespective of periodontal status, showing no association with pocket depth.

Al Asqah et al. \[[@B35]\] reported that 60% (37/62) of the periodontitis patients in their study harbored *H. pylori* in their stomach compared to only 33% (13/39) of the patients without periodontitis. Furthermore, they reported that the prevalence of *H. pylori* in the dental plaque was higher among periodontitis patients (79%, 49/62) than in patients without periodontitis (43%, 17/39). They also reported that the presence of the bacterium in both locations was higher among periodontitis patients (46.8%, 29/62) than in patients without periodontitis (10.3%, 4/39).

2.12. Effects of Systemic Anti-*H. pylori* Therapy on Dental Plaque {#sec2.12}
-------------------------------------------------------------------

A total of 8 studies \[[@B30], [@B40]--[@B46]\] were reviewed in which the effect of anti-*H. pylori* therapy on its presence in the dental plaque was evaluated. The summary of these studies are given in [Table 7](#tab7){ref-type="table"}. In 6 of these 8 studies, PCR was used to detect *H. pylori* in dental plaque while in one study \[[@B30]\] urease test was used and in the other \[[@B46]\] smear cytology was used. In their study on 82 *H. pylori* positive patients, Butt et al. \[[@B46]\] treated 27 of these patients with anti-*H. pylori* therapy (triple therapy-2 antibiotics and 1 proton pump inhibitor) alone and reported 100% prevalence of *H. pylori* in the dental plaque of these 27 patients after 10 days of treatment. Gürbüz et al. \[[@B30]\] conducted a study among 75 dyspeptic patients in which *H. pylori* positive patients were treated with anti-*H. pylori* therapy. In this study, initially 68 (91%) patients were positive for *H. pylori* in dental plaque and 65 (87%) were positive for *H. pylori* in the gastric mucosa. When the procedures were repeated after 1 month following treatment, the authors reported that all the dental plaque samples were positive for *H. pylori* although they had not mentioned the number of patients treated with anti-*H. pylori* therapy. Among the studies in which PCR was employed for pathogen detection, Gao et al. \[[@B44]\] reported that, among 37 *H. pylori* positive patients, the prevalence of plaque colonization was 29.7% and 43.2%, respectively, at 4 weeks and 1 year after anti-*H. pylori* therapy. Gebara et al. \[[@B42]\], in their study on 30 dental patients with periodontitis and *H. pylori* infection, reported an increase in the prevalence of plaque colonization from 20% to 30% in supragingival plaque and from 26.6% to 46.7% in subgingival plaque. Suk et al. \[[@B45]\] reported that, after anti-*H. pylori* therapy, the microorganism persisted in the dental plaque of 92.9% (*n* = 26) of the 28 patients who harbored the organism in the dental plaque before anti-*H. pylori* therapy. Zaric et al. \[[@B40]\] reported that, after anti-*H. pylori*therapy, the pathogen could be detected in the dental plaque of 66.7% (*n* = 14) of the 21 patients who were positive for the microorganism both in the subgingival plaque and gastric mucosa before the intervention. Miyabayashi et al. \[[@B43]\] in their study on 47 dyspeptic patients reported 48.9% (*n* = 23) positive for oral *H. pylori* and 38.3% (*n* = 18) had *H. pylori* in plaque before anti-*H. pylori* treatment. At 4 weeks after treatment, they reported that 31.9% of the patients were positive for oral *H. pylori*. However, they did not specify how many patients were positive for the microorganism in the dental plaque. Contrary to these studies, Bago et al. \[[@B41]\], reported that 21 patients were positive for *H. pylori* in the dental plaque in a study on 56 chronic periodontitis patients who harbored *H. pylori* in the gastric mucosa. They reported complete eradication of *H. pylori* from dental plaque in all of the 21 patients following anti-*H. pylori* therapy consisting of 2 antibiotic and 1 proton pump inhibitor (PPI).

2.13. Effects of Periodontal Therapy on Dental Plaque-Associated *H. pylori* {#sec2.13}
----------------------------------------------------------------------------

Three studies have evaluated the effects of nonsurgical periodontal therapy on *H. pylori* residing in the dental plaque ([Table 8](#tab8){ref-type="table"}). Butt et al. \[[@B46]\] categorized 82 patients who harbored *H. pylori* in their dental plaque into 3 groups based on the type of intervention---Group 1 which received only anti-*H. pylori* therapy (*n* = 27), Group 2 which received anti-*H. pylori* therapy plus periodontal therapy (*n* = 25), and Group 3 which received only periodontal therapy (*n* = 30). Ten days after treatment, the prevalence of *H. pylori* in dental plaque for Groups 1, 2, and 3 were 100%, 16%, and 10%, respectively. In a study on 43 patients who harbored *H. pylori* both in the subgingival plaque and gastric mucosa, Zaric et al. \[[@B40]\] reported that, among 22 patients who received both anti-*H. pylori* therapy and periodontal therapy, *H. pylori* was detected in the dental plaque of only 6 patients 3 months after completion of treatment compared to 21 patients who received only anti-*H. pylori* therapy among whom the prevalence after intervention was 66.7%. Gao et al. \[[@B44]\], in their study to evaluate the effects of combination of anti-*H. pylori* therapy (triple therapy) and periodontal therapy for the management of *H. pylori* infection, treated 37 patients with anti-*H. pylori* therapy alone and 43 patients with a combination of anti-*H. pylori* therapy and periodontal therapy. The detection rates of *H. pylori* in the dental plaque for both groups at 4 weeks after intervention were 29.7% and 4.7%, respectively, and 43.2% and 18.6%, respectively, one year after intervention.

2.14. Effects of Periodontal Therapy on Gastric *H. pylori* Infection {#sec2.14}
---------------------------------------------------------------------

Three studies have evaluated the effects of periodontal therapy on gastric *H. pylori* infection. Gao et al. \[[@B44]\] reported that, among 43 *H. pylori* positive patients who received both anti-*H. pylori* therapy and periodontal therapy, the gastric eradication rate at 4 weeks and 1 year after intervention was 81.4% and 62.8%, respectively, while the eradication rates at same time periods among 37 *H. pylori* positive patients who received only anti-*H. pylori* therapy were 73% and 32.4%. Zaric et al. \[[@B40]\] conducted a study among 43 patients who were positive for *H. pylori* in both subgingival plaque and gastric mucosa in which 21 patients received only anti-*H. pylori* therapy while 22 received anti-*H. pylori* therapy along with periodontal therapy. Three months after completion of treatment, 77.3% of the patients who received both anti-*H. pylori* therapy and periodontal therapy showed gastric eradication compared to only 47.6% of the patients who received only anti-*H. pylori* therapy. The authors also reported that eradication in the stomach coincided with eradication from the oral cavity; that is, all 16 of the individuals who received both forms of therapy and showed eradication of oral *H. pylori*, also showed eradication of gastric *H. pylori*. Five of the participants in this group who were positive for oral samples were positive for gastric *H. pylori*as well. Jia et al. \[[@B47]\], in a study on 107 *H. pylori*positive dyspeptic patient, reported that, 6 months after complete eradication of *H. pylori* from gastric mucosa, reinfection of the gastric mucosa by the bacterium was observed in 84.31% of the patients who did not receive any form of dental plaque control compared to only 19.64% of the patients who received dental plaque control and full-mouth scaling and root planing.

3. Conclusion {#sec3}
=============

*H. pylori*is a major etiologic factor in the development of gastritis and peptic ulcer disease. There is sufficient evidence on the presence of *H. pylori* in the subgingival oral biofilm which could act as a reservoir for harboring *H. pylori*, leading to gastric reinfection. Hence, it is imperative to adapt a multidisciplinary clinical management protocol, merging the triple therapy to periodontal mechanical treatment and chemical antiseptic disinfection. Further research that may be directed towards controlled randomized clinical trials are necessary for testing the efficacy of the multidisciplinary therapeutic regimen.
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###### 

Summary of studies in which the presence of *H. pylori* in dental plaque was determined by rapid urease test/CLO test.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Author(s)                      Year   Sample size                                                                                                                          Prevalence of\
                                                                                                                                                                                   *H. pylori*
  ----- ------------------------------ ------ ------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------
  1     Assumpção et al. \[[@B48]\]    2010   99 adult patients who underwent upper gastrointestinal endoscopy                                                                     52%

  2     Al Asqah et al. \[[@B35]\]     2009   Sixty-two dyspeptic patients with periodontitis and 39 dyspeptic patients without periodontitis                                      Overall-65%; 79% in periodontitis group and 43% in nonperiodontitis group

  3     Anand et al. \[[@B38]\]        2006   Sixty-five dyspeptic patients with *H. pylori* infection (cases) and 69 dyspeptic patients without *H. pylori* infection (control)   Overall-79.9%; 89% among cases and 71% among controls

  4     Chitsazi et al. \[[@B23]\]     2006   88 dyspeptic patients-44 with *H. pylori* infection and 44 without *H. Pylori* infection                                             Overall 18.2%; 36.4% in HP positive group

  5     Choudhury et al. \[[@B22]\]    2003   124 patients with dyspepsia                                                                                                          43%

  6     Gürbüz et al. \[[@B30]\]       2003   75 dyspeptic patients                                                                                                                91.7%

  7     Suk et al. \[[@B45]\]          2002   Sixty-five patients with dyspeptic symptoms                                                                                          100%

  8     Avcu et al. \[[@B21]\]         2001   241 *H. pylori* positive patients with gastric histologic changes                                                                    44.8%

  9     Özdemir et al. \[[@B49]\]      2001   81 dyspeptic patients                                                                                                                79%

  10    Qureshi et al. \[[@B50]\]      1999   60 dyspeptic patients                                                                                                                50%

  11    Contractor et al. \[[@B51]\]   1998   100 healthy subjects                                                                                                                 81%
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of studies in which the presence of *H. pylori* in dental plaque was determined by PCR.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Authors                            Year   Target gene                                   Sample size                                                                                                                                                                                                           Prevalence of *H. pylori*
  ----- ---------------------------------- ------ --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1     Momtaz et al. \[[@B52]\]           2012   ureC, cagA, and vacA                          300 patients with gastroduodenal diseases                                                                                                                                                                             None of the plaque samples showed presence of *H. pylori*

  2     Agarwal and Jithendra \[[@B31]\]   2012   16S rRNA                                      30 *H. pylori* positive and 20 *H. pylori* negative patients                                                                                                                                                          Overall-42%; in *H. pylori* positive group-60%; in *H. pylori* negative group-15%.

  3     Bago et al. \[[@B41]\]             2011   16S rDNA                                      56 patients with chronic periodontitis and gastric *H. pylori* positive                                                                                                                                               37.5%

  4     Chaudhry et al. \[[@B53]\]         2011   16srRNA and 860 bp DNA region                 89 dyspeptic patients reporting for endoscopy                                                                                                                                                                         51.6% for both genes; 62.9% for 16srRNA; 61% for 860 bp DNA region and 73% if either of the 2 regions are considered

  5     Gao et al. \[[@B44]\]              2011   ureC and cagA genes                           96 patients with *H. pylori* infection                                                                                                                                                                                82.3%

  6     Wichelhaus et al. \[[@B54]\]       2011   860bp DNA                                     11 orthodontic patients                                                                                                                                                                                               36%

  7     Assumpção et al. \[[@B48]\]        2010   vacA and cagA                                 99 adult patients who underwent upper gastrointestinal endoscopy                                                                                                                                                      72% samples were positive for *H. pylori*. 63 of 71 positive dental plaque samples were positive for vacA and cagA. 58/71 were positive for cagA while vacA genotypes had a prevalence ranging from 13--59%

  8     Rasmussen et al. \[[@B55]\]        2010   Genomic DNA                                   78 dyspeptic patients                                                                                                                                                                                                 47.4%

  9     Eskandari et al. \[[@B56]\]        2010   16S rRNA                                      67 patients with chronic periodontitis-23 with *H. pylori* positive gastritis                                                                                                                                         5.97%

  10    Silva et al. \[[@B57]\]            2010   vacA and 16S rDNA                             30 dyspeptic patients                                                                                                                                                                                                 20% by 16S rDNA and 6.7% by vacA

  11    Silva et al. \[[@B58]\]            2010   16S rRNA                                      115 patients                                                                                                                                                                                                          11.3%

  12    Silva et al. \[[@B59]\]            2009   16s ribosomal and cagA genes                  32 with *H. pylori* positive with gastric disease and 32 with *H. pylori*positive with no gastric disease                                                                                                             Overall-17.7%. Among cases, *H. pylori* DNA detected in 36.6% and cagA gene detected in 3 out of 11 (27.3%) samples. In control group 0%

  13    Gonçalves\                         2009   JW22 and JW23 primers/16S rRNA                23, HIV seropositive individuals of whom 13 with chronic periodontitis and 10 with periodontally healthy and 31 HIV seronegative individuals of whom 17 had chronic periodontitis and 14 were periodontally healthy   Not specified
        et al. \[[@B60]\]                                                                                                                                                                                                                                                                                             

  14    Liu et al. \[[@B61]\]              2009   860 bp fragment                               443 dyspeptic patients                                                                                                                                                                                                59.4%

  15    Bürgers et al. \[[@B36]\]          2008   16S rDNA                                      94 patients who underwent upper gastrointestinal endoscopy                                                                                                                                                            5.4%

  16    Liu et al. \[[@B62]\]              2008   860 bp fragment                               214 children                                                                                                                                                                                                          58.9%

  17    Teoman et al. \[[@B25]\]           2007   Urease A                                      67 dyspeptic patients                                                                                                                                                                                                 28.3%

  18    Olivier et al. \[[@B63]\]          2006   urease AB gene; phosphoglucosamine\           74 healthy members of a rural community                                                                                                                                                                               0
                                                  mutase (*glmM*) gene; and 860 bp DNA region                                                                                                                                                                                                                         

  19    Kignel et al. \[[@B64]\]           2005   16S rRNA                                      49 dyspeptic patients                                                                                                                                                                                                 2%

  20    Fritscher et al. \[[@B65]\]        2004   860 bp fragment                               53 patients with recurrent aphthous stomatitis and 52 patients without RAS                                                                                                                                            Overall-3.8%; 5.7% in cases and 1.9% among controls

  21    Gebara et al. \[[@B66]\]           2004   16S rDNA                                      30 dentate patients with gingivitis/periodontitis and *H. pylori* infection                                                                                                                                           20% in supra-gingival plaque and 26.6% in subgingival plaque

  22    Umeda et al. \[[@B37]\]            2003   16S rRNA                                      56 dental patients                                                                                                                                                                                                    25%

  23    Goosen et al. \[[@B67]\]           2002                                                                                                                                                                                                                                                                        

  24    Berroteran et al. \[[@B39]\]       2002   Urease genes                                  32 dyspeptic patients and 20 asymptomatic controls                                                                                                                                                                    Overall-28.9%; 37.5% among dyspeptic patients and 15% among controls

  25    Suk et al. \[[@B45]\]              2002   cagA                                          Sixty-five patients with dyspeptic symptoms                                                                                                                                                                           43.1%

  26    Miyabayashi et al. \[[@B43]\]      2000   ureA                                          47 patients with chronic gastritis or peptic ulcer                                                                                                                                                                    38.3%

  27    Song et al. \[[@B68]\]             2000   860 bp fragment                               Forty-two patients who underwent upper gastrointestinal endoscopy                                                                                                                                                     Overall 97% (82% in molar region, 64% in premolar region and 59% in incisor region)

  28    Song et al. \[[@B69]\]             2000   860 bp fragment                               20 dyspeptic patients                                                                                                                                                                                                 Not specified

  29    Song et al. \[[@B70]\]             2000   860 bp fragment                               21 patients                                                                                                                                                                                                           100%

  30    Song et al. \[[@B71]\]             1999   Urease A, 16S rRNA, and 860 bp fragment       40 dental patients                                                                                                                                                                                                     

  31    Dowsett et al. \[[@B18]\]          1999                                                                                                                                                                                                                                                                       Not specified

  32    Oshowo et al. \[[@B32]\]           1998   16S rRNA                                      208 dyspeptic patients-116 *H. pylori* positive and 92 *H. pylori* negative                                                                                                                                           Overall 6.25% all in *H. pylori* positive

  33    Hardo et al. \[[@B24]\]            1995   16S rRNA                                      62 dyspeptic patients                                                                                                                                                                                                 1.6%

  34    Mapstone et al. \[[@B72]\]         1993   16S rRNA                                      21 dyspeptic patients-13 with *H. pylori* associated gastritis and 8 who had normal histology                                                                                                                         Overall-9.5%; 15.4% in gastritis group and 0 in histologically normal group-overall prevalence-9.5%

  35    Nguyen et al. \[[@B73]\]           1993   16S rRNA                                      25 dyspeptic patients                                                                                                                                                                                                 Overall 28% all in *H. pylori* positive; among *H. pylori* positive individuals 38.8%.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of studies in which the presence of *H. pylori* in dental plaque was determined by culture.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Authors                                                  Year   Sample size                                                                   Prevalence of\
                                                                                                                                                      *H. pylori*
  ----- -------------------------------------------------------- ------ ----------------------------------------------------------------------------- ---------------------------------------------------------------------------------
  1     Agarwal and Jithendra \[[@B31]\]                         2012   30 *H. pylori* positive and 20 *H. pylori* negative patients                  Overall-18%; in *H. pylori* positive group-30%; in *H. pylori* negative group-0

  2     Loster et al. \[[@B74]\]                                 2009   Forty six dentists without known co-morbidities                               48%

  3     Teoman et al. \[[@B25]\]                                 2007   67 dyspeptic patients                                                         0

  4     Czesnikiewicz-Guzik et al. \[[@B75]\]                    2005   100 female patients                                                           48.3%

  5     Cze$\acute{\text{s}}$nikiewicz-Guzik et al. \[[@B33]\]   2004   100 female patients                                                           48.3%

  6     Umeda et al. \[[@B37]\]                                  2003   18 dental patients                                                            5.6%

  7     Goosen et al. \[[@B67]\]                                 2002   58 clinically healthy volunteers                                              13.8% of which only 5.2% were positive in PCR analysis

  8     Checchi et al. \[[@B28]\]                                2000   35 patients from a Periodontology clinic                                      8.6%

  9     Oshowo et al. \[[@B32]\]                                 1998   208 dyspeptic patients-116 *H. pylori* positive and 92 *H. pylori* negative   Overall 1% all in *H. pylori* positive

  10    Hardo et al. \[[@B24]\]                                  1995   62 dyspeptic patients                                                         0

  11    Krajden et al. \[[@B16]\]                                1989   71 patients undergoing endoscopy                                              1.4%
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of studies in which the presence of *H. pylori* in dental plaque was determined by EIA.

  No.   Authors                         Year   Sample size                                                                                Prevalence of *H. pylori*
  ----- ------------------------------- ------ ------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------
  1     Namiot et al. \[[@B26]\]        2010   155 patients                                                                               65.6%
  2     Leszczyńska et al. \[[@B27]\]   2009   164 dyspeptic patients referred for endoscopy-95 *H. pylori* infected and 69 noninfected   82.1% in *H. pylori* positive subjects and 17.7% in *H. pylori* negative subjects
  3     Checchi et al. \[[@B28]\]       2000   35 patients from a Periodontology clinic                                                   11%
  4     Savoldi et al. \[[@B29]\]       1998   80 dyspeptic patients                                                                      0

###### 

Data regarding the coinfection of *H*. *pylori* and oral infection.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Authors                                 Year   Method used to detect *H. pylori*   Sample size                                                                                                       Prevalence of coinfection of *H. pylori*
  ----- --------------------------------------- ------ ----------------------------------- ----------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  1     Agarwal and Jithendra \[[@B31]\]        2012   PCR-16S rRNA                        30 *H*. *pylori* positive and 20 *H*. *pylori* negative patients                                                  Overall-36%; in *H. pylori* positive group-60%

  2     Agarwal and Jithendra \[[@B31]\]        2012   Culture                             30 *H. pylori* positive and 20 *H. pylori* patients                                                               Overall-18%; in *H. pylori* positive group-30%

  3     Bago et al. \[[@B41]\]                  2011   PCR-16S rDNA                        56 patients with chronic periodontitis and gastric *H. pylori* positive                                           37.5%

  4     Silva et al. \[[@B58]\]                 2010   PCR-16S rRNA                        115 patients                                                                                                      Overall-8.7%; among *H. pylori* positive group-14.93%

  5     Eskandari et al. \[[@B56]\]             2010   PCR-16S rRNA                        67 patients with chronic periodontitis-23 with *H. pylori* positive gastritis                                     Overall-5.97%; among *H. pylori* positive group-17.39%

  6     Al Asqah et al. \[[@B35]\]              2009   RUT                                 62 dyspeptic patients with periodontitis and 39 dyspeptic patients without periodontitis                          Overall-32.7%; 66% among *H. pylori* positive patients

  7     Liu et al. \[[@B61]\]                   2009   PCR-860-bp fragment                 443 dyspeptic patients                                                                                            Overall-42.7%; among *H. pylori* positive subjects-69.2% (75.5% in 18--29 years; 61.7% in 30--39 years; 79.7% in 40--49 years; 76.6% in ≥50 years)

  8     Leszczyńska\                            2009   EIA                                 164 dyspeptic patients referred for endoscopy-95 *H. pylori* positive and 69 noninfected                          Overall-47.6%; 82.1% in *H. pylori* positive
        et al. \[[@B27]\]                                                                                                                                                                                    

  9     Silva et al. \[[@B59]\]                 2009   PCR-16s ribosomal and cagA genes    30 with *H. pylori*positive with gastric disease and 32 with *H. pylori*positive with no gastric disease          Overall-17.7%. Among cases, *H. pylori* DNA detected in 36.6%, and cagA gene detected in 3 out of 11 samples. In control group-0%

  10    Bürgers et al. \[[@B36]\]               2008   PCR-16S rDNA                        94 patients who underwent upper gastrointestinal endoscopy                                                        Overall-1.1% 3.5% of *H. pylori* positive subjects

  11    Teoman et al. \[[@B25]\]                2007   PCR-Urease A                        67 dyspeptic patients                                                                                             Overall-25.4%; among *H. pylori* positive group-36.2%

  12    Anand et al. \[[@B38]\]                 2006   RUT                                 Sixty-five dyspeptic patients with *H. pylori* infection and 69 dyspeptic patients without *H. pylori*infection   Overall-43.3%; 89.2% among cases

  13    Chitsazi et al. \[[@B23]\]              2006   RUT                                 88 dyspeptic patients-44 with *H. pylori* infection and 44 without *H. pylori* infection                          Overall 34.1%; 36.4% in *H. pylori* positive group

  14    Agüloğlu et al. \[[@B76]\]              2006   CLO test                            468 patients who were *H. pylori* positive by CLO test                                                            25.2%

  15    Agüloğlu et al. \[[@B76]\]              2006   EIA                                 318 patients who were *H. pylori* positive by EIA                                                                 23.6%

  16    Agüloğlu et al. \[[@B76]\]              2006   Culture                             295 patients who were *H. pylori* positive by culture                                                             14.6%

  17    Czesnikiewicz-Guzik et al. \[[@B75]\]   2005   Culture                             100 female patients                                                                                               6.9%

  18    Kignel et al. \[[@B64]\]                2005   PCR-16S rRNA                        49 dyspeptic patients                                                                                             2% of the total population and 5% of *H. pylori* positive subjects

  19    Umeda et al. \[[@B37]\]                 2003   PCR-16S rRNA                        56 dental patients                                                                                                Overall-14.3%; among *H. pylori* positive group-28.6%.

  20    Gürbüz et al. \[[@B30]\]                2003   RUT                                 75 dyspeptic patients                                                                                             Overall-81.3%; among *H. pylori* positive subjects-93.9%

  21    Berroteran et al. \[[@B39]\]            2002   PCR-Urease genes                    32 dyspeptic patients and 20 asymptomatic controls                                                                Overall-13.5%; 58% among dyspeptic patients

  22    Suk et al. \[[@B45]\]                   2002   PCR-cagA                            65 patients with dyspeptic symptoms                                                                               Overall-43.1%, 73.7% among *H. pylori* positive patients

  23    Suk et al. \[[@B45]\]                   2002   RUT                                 65 patients with dyspeptic symptoms                                                                               Overall-58.5%, 100% among *H. pylori* positive patients

  24    Özdemir et al. \[[@B49]\]               2001   CLO test                            81 dyspeptic patients                                                                                             Overall-64.2%; among *H. pylori* positive group-82.5%.

  25    Song et al. \[[@B70]\]                  2000   PCR-860-bp fragment                 21 patients                                                                                                       Overall-47.6%; among *H. pylori* positive group-100%

  26    Qureshi et al. \[[@B50]\]               1999   CLO test                            60 dyspeptic patients                                                                                             Overall 33.3%; in *H. pylori* positive 55.6%

  27    Oshowo et al. \[[@B32]\]                1998   PCR-16S rRNA and culture            208 dyspeptic patients-116 *H. pylori* positive and 92 *H. pylori* negative                                       By PCR-Overall 6.25%; in *H. pylori* positive-11.2%\
                                                                                                                                                                                                             By culture-Overall 1%; in *H. pylori* positive-1.7% By both methods-Overall 7.2% in *H. pylori* positive-12.9%.

  28    Hardo et al. \[[@B24]\]                 1995   16S rRNA                            62 dyspeptic patients                                                                                             0

  29    Mapstone et al. \[[@B72]\]              1993   PCR-16S rRNA                        21 dyspeptic patients-13 with *H. pylori* associated gastritis and 8 who had normal histology                     15.4% in gastritis group-overall prevalence 9.5%

  30    Nguyen et al. \[[@B73]\]                1993   PCR-16S rRNA                        25 dyspeptic patients                                                                                             Overall 28%, among *H. pylori* positive individuals 38.8%

  31    Krajden et al. \[[@B16]\]               1989   Culture                             71 patients undergoing endoscopy                                                                                  1.4% of the total population and 3.5% of *H. pylori* positive subjects
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Data regarding the association between periodontal diseases and *H*. *pylori* infection.

  No.   Authors                        Year   Definition of gingival/periodontal disease                                                                                      Sample size                                                                                                                                                                           Association with oral *H. pylori*                                            Association with gastric *H. pylori*
  ----- ------------------------------ ------ ------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------
  1     Silva et al. \[[@B58]\]        2010   At least 4 teeth with PD ≥ 5 mm and CAL \> 3 mm                                                                                 115 dyspeptic patients                                                                                                                                                                Significant                                                                  Not evaluated
  2     Namiot et al. \[[@B26]\]       2010   Russell\'s periodontal index                                                                                                    155 dyspeptic patients                                                                                                                                                                Nonsignificant                                                               Not evaluated
  3     Gonçalves et al. \[[@B60]\]    2009   At least 3 sites with PD ≥ 5 mm and/or CAL ≥ 4 mm and BOP                                                                       23 HIV seropositive patients of whom 13 had periodontitis and 10 were periodontally healthy; 31 HIV seronegative patients of 17 had periodontitis and 14 were periodontally healthy   Significant                                                                   
  4     Al Asqah et al. \[[@B35]\]     2009   BOP + PD ≥ 3 mm on at least 4 teeth                                                                                             Dyspeptic patients-62 patients with periodontitis and 39 without periodontitis                                                                                                        Significant                                                                  Significant
  5     Liu et al. \[[@B61]\]          2009   Gingival index                                                                                                                  443 dyspeptic patients                                                                                                                                                                Significant                                                                  Not evaluated
  6     Zaric et al. \[[@B40]\]        2009   Mean PD, CAL, and gingival index scores                                                                                         66 dyspeptic patients with *H. pylori* infection of gastric mucosa                                                                                                                    Significant for mean PD and CAL; not significant for gingival index scores   Not evaluated
  7     Bürgers et al. \[[@B36]\]      2008   Periodontal Screening Index                                                                                                     94 dyspeptic patients                                                                                                                                                                 Nonsignificant                                                               Nonsignificant
  8     Namiot et al. \[[@B77]\]       2007   Russell\'s periodontal index                                                                                                    137 *H. pylori* positive patients with peptic ulcer                                                                                                                                   Outcome variable was efficacy of HP eradication                              Nonsignificant (outcome variable was efficacy of *H. pylori* eradication)
  9     Anand et al. \[[@B38]\]        2006   Patients with one or more sites with a PD ≥ 3 mm and CAL ≥ 3 mm at the same site                                                Sixty-five dyspeptic patients with *H. Pylori* infection and 69 dyspeptic patients without *H. pylori* infection                                                                      Not evaluated                                                                Nonsignificant
  10    Gebara et al. \[[@B66]\]       2004   Gingivitis group-patients with PD ≤ 3 mm and BOP on at least 4 sites; periodontitis group-BOP + PD ≥ 5 mm on at least 4 teeth   15 gingivitis and 15 periodontitis patients-All were *H. pylori* positive in antral mucosa                                                                                            Nonsignificant                                                                
  11    Umeda et al. \[[@B37]\]        2003   Presence of periodontal pockets ≥ 4 mm                                                                                          28 patients who harbored *H. pylori* in stomach/duodenum                                                                                                                              Significant                                                                  Not evaluated
  12    Choudhury et al. \[[@B22]\]    2003   CPI                                                                                                                             124 dyspeptic patients                                                                                                                                                                Significant                                                                  Not evaluated
  13    Dye et al. \[[@B34]\]          2002   Presence of 1 dental site with PD ≥ 5 mm                                                                                        Data from 4504 participants of NHANES III Survey                                                                                                                                      Not evaluated                                                                Significant
  14    Berroteran et al. \[[@B39]\]   2002   Gingival index-scoring 0--3                                                                                                     32 dyspeptic patients and 20 asymptomatic controls                                                                                                                                    Nonsignificant                                                               Nonsignificant
  15    Dowsett et al. \[[@B18]\]      1999   Full mouth periodontal examination                                                                                              242 subjects                                                                                                                                                                          Nonsignificant                                                               Nonsignificant
  16    Savoldi et al. \[[@B29]\]      1998   Gingival index                                                                                                                  80 dyspeptic patients                                                                                                                                                                 Nonsignificant-None of the plaque samples were positive for HP               Nonsignificant
  17    Hardo et al. \[[@B24]\]        1995   CPITN                                                                                                                           62 dyspeptic patients                                                                                                                                                                 Nonsignificant                                                               Nonsignificant
  18    Nguyen et al. \[[@B73]\]       1993   Gingival index                                                                                                                  25 dyspeptic patients                                                                                                                                                                 Nonsignificant                                                               Nonsignificant

###### 

Data regarding effects of anti-*H*. *pylori* therapy on dental plaque.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.   Authors                         Year   Method used to detect *H. pylori*   Sample size                                                                                                                                                                                                                        Prevalence of *H. pylori*                                                           Prevalence after anti-*H. pylori* therapy                                                    Effect on *H. pylori* infection
  ----- ------------------------------- ------ ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1     Gao et al. \[[@B44]\]           2011   PCR-ureC and cagA genes             80 patients with *H. pylori* infection-37 treated with anti-*H. pylori* therapy and 43 treated with anti-*H. pylori* therapy and periodontal therapy                                                                                                                                                                   After 4 weeks-29.7% in gp A and 4.7% in gp B; after 1 year-43.2% in gp A and 18.6% in gp B   Eradication rate of gastric *H. pylori*. After 4 weeks-73% in gp A and 81.4% in gp B\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       After 1 year-32.4% in gp A and 62.8% in gp B

  2     Bago et al. \[[@B41]\]          2011   PCR-16S rDNA                        56 patients with chronic periodontitis and gastric *H. pylori* positive                                                                                                                                                            37.5% (*n* = 21)                                                                    0                                                                                            Eradication rate in stomach was 76.2%

  3     Zaric et al. \[[@B40]\]         2009   PCR                                 44 patients: 21 patients positive for *H. pylori* in subgingival dental plaque and gastric mucosa and 23 patients who were positive for *H. pylori* only in gastric mucosa-all 44 received only for *H. pylori* (triple) therapy                                                                                       In G^+^O^+^t-66.7%                                                                           In the G^+^O^+^t group, only 47.6%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       showed eradication of gastric *H. pylori* compared to 87.4% in G^+^O^−^t

  4     Gebara et al. \[[@B42]\]        2006   PCR-16S rDNA                        30 dentate patients with gingivitis/periodontitis and *H. pylori* infection who received anti-*H. pylori* therapy                                                                                                                  20% (*n* = 6) in supra-gingival plaque and 26.6% (*n* = 8) in sub-gingival plaque   30% in supra-gingival plaque and 46.7% in sub-gingival plaque                                 

  5     Gürbüz et al. \[[@B30]\]        2003   CLO test                            75 dyspeptic patients of which 61 were *H. pylori* positive and also had *H. pylori* in dental plaque                                                                                                                              90.7% (*n* = 68); 81.3% (*n* = 61) had co-infection                                 100%                                                                                          

  6     Suk et al. \[[@B45]\]           2002   PCR-cagA                            Sixty-five patients with dyspeptic symptoms                                                                                                                                                                                        Overall-43.1% (*n* = 28), 73.7% (28/38) among *H. pylori* positive patients         92.9%                                                                                         

  7     Butt et al. \[[@B46]\]          2001   Smear cytology                      82 patients positive for *H. pylori* in dental plaque: 27 received only anti-*H. pylori* therapy (gp 1); 25 received anti-HP therapy + periodontal therapy (gp 2); 30 received only periodontal therapy (gp 3)                     100%                                                                                100% in gp 1; 16% in gp 2; 10% in gp 3                                                       

  8     Miyabayashi et al. \[[@B43]\]   2000   PCR-ureA                            47 patients with chronic gastritis or peptic ulcer-48.9% (*n* = 23) were positive for oral HP and 38.3% (*n* = 18) had HP in plaque                                                                                                                                                                                    Oral prevalence at 4 weeks-31.9                                                              At 4 weeks-91.6% of subjects negative for oral *H. pylori* were successfully eradicated of HP infection compared to 52.2% in oral *H. pylori* positive patients. At 2 years-95.8% of subjects negative for oral *H. pylori* were successfully eradicated of *H. pylori* infection compared to 69.5% in oral *H. pylori* positive patients
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Data regarding effects of periodontal therapy on *H*. *pylori* in dental plaque and gastric infection.

  No.   Authors                   Year   Method used to detect *H. pylori*   Sample size                                                                                                                                                                                                                           Prevalence of *H. pylori*   Prevalence after anti-*H. pylori* therapy                                                    Effect on *H. pylori* infection
  ----- ------------------------- ------ ----------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------- -------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1     Gao et al. \[[@B44]\]     2011   PCR-ureC and cagA genes             80 patients with *H. pylori* infection-37 treated with anti-HP therapy (gp A) and 43 treated with anti-*H. pylori* therapy and periodontal therapy (gp B)                                                                                                         After 4 weeks-29.7% in gp A and 4.7% in gp B; after 1 year-43.2% in gp A and 18.6% in gp B   Eradication rate of gastric *H. pylori.* After 4 weeks-73% in gp A and 81.4% in gp B, After 1 year-32.4% in gp A and 62.8% in gp B
  2     Zaric et al. \[[@B40]\]   2009   PCR                                 43 patients positive for *H. pylori* in sub gingival dental plaque and gastric mucosa: 21 received only anti-*H. pylori* triple therapy (G^+^O^+^t); 22 received anti-*H. pylori* triple therapy + periodontal therapy (G^+^O^+^tp)                               In G^+^O^+^t-66.7%; in G^+^O^+^tp-27.3%                                                      In the G^+^O^+^tp group, 77.3% showed eradication of gastric *H. pylori* compared to 47.6% in G^+^O^+^t. *H. pylori*eradication in the stomach and the oral cavity coincided---that is, all 16 of the individuals negative for oral *H. pylori*were also negative for gastric *H. pylori*. Five of the participants positive for oral samples were positive for gastric *H. pylori*as well.
  3     Jia et al. \[[@B47]\]     2009                                       107 dyspeptic patients-56 received dental plaque control (test) and 51 did not (control)                                                                                                                                                                                                                                                                       Prevalence of *H. pylori* in gastric mucosa was 19.64% in test group and 84.31% in control group
  4     Butt et al. \[[@B46]\]    2001   Smear cytology                      82 patients positive for *H. pylori* in dental plaque: 27 received only anti-*H. pylori* therapy (gp 1); 25 received anti-*H. pylori* therapy + periodontal therapy (gp 2); 30 received only periodontal therapy (gp 3)               100%                        100% in gp 1; 16% in gp 2; 10% in gp 3                                                        
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